Proteomic approaches for studying chemoresistance in cancer.
about
Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancer.Separation of biological proteins by liquid chromatography.Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion: proteomic approach using fluorescent two-dimensional differential gel electrophoresis.
P2860
Proteomic approaches for studying chemoresistance in cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Proteomic approaches for studying chemoresistance in cancer.
@ast
Proteomic approaches for studying chemoresistance in cancer.
@en
type
label
Proteomic approaches for studying chemoresistance in cancer.
@ast
Proteomic approaches for studying chemoresistance in cancer.
@en
prefLabel
Proteomic approaches for studying chemoresistance in cancer.
@ast
Proteomic approaches for studying chemoresistance in cancer.
@en
P2093
P2860
P356
P1476
Proteomic approaches for studying chemoresistance in cancer
@en
P2093
Annalisa Castagna
Natascia Campostrini
Paolo Antonioli
Pier Giorgio Righetti
Sabina Carla Righetti
P2860
P304
P356
10.1586/14789450.2.2.215
P577
2005-04-01T00:00:00Z